Onconova Therapeutics Inc (ONTX) Insider Trading
- $23,698,668.98
- $2,952,748.58
- Jan. 28, 2022
- Tyndall Capital Partners L P
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 28, 2022 | SVP | 1,500 | $1.67 | Buy | $2,505.00 | |
Jan. 21, 2022 | SVP | 1,500 | $2.02 | Buy | $3,030.00 | |
Jan. 14, 2022 | SVP | 1,500 | $2.20 | Buy | $3,300.00 | |
Jan. 7, 2022 | SVP | 1,500 | $2.39 | Buy | $3,585.00 | |
Nov. 19, 2021 | SVP | 1,000 | $3.16 | Buy | $3,160.00 | |
Sept. 28, 2021 | Director | 5,952 | $4.20 | Buy | $24,998.40 | |
Sept. 28, 2021 | Insider | 2,381 | $4.20 | Buy | $10,000.20 | |
Feb. 16, 2021 | SVP | 12,000 | $1.00 | Buy | $12,000.00 | |
Feb. 16, 2021 | Director | 25,000 | $1.00 | Buy | $25,000.00 | |
Feb. 16, 2021 | CFO | 15,000 | $1.00 | Buy | $15,000.00 | |
Feb. 16, 2021 | Insider | 20,000 | $1.00 | Buy | $20,000.00 | |
Dec. 11, 2020 | SVP | 30,000 | $0.32 | Buy | $9,600.00 | |
Nov. 27, 2020 | CFO | 4,614 | $0.26 | Buy | $1,199.64 | |
Nov. 25, 2020 | SVP | 20,000 | $0.26 | Buy | $5,200.00 | |
Nov. 25, 2020 | CFO | 16,755 | $0.26 | Buy | $4,356.30 | |
Nov. 25, 2020 | Insider | 40,000 | $0.26 | Buy | $10,400.00 | |
Nov. 24, 2020 | Director | 38,774 | $0.26 | Buy | $10,081.24 | |
Aug. 27, 2020 | Director | 527,863 | $0.27 | Sell | $142,523.01 | |
May 19, 2020 | SVP | 15,000 | $0.37 | Buy | $5,550.00 | |
May 19, 2020 | Director | 10,000 | $0.44 | Buy | $4,400.00 | |
May 19, 2020 | CFO | 21,000 | $0.37 | Buy | $7,770.00 | |
May 19, 2020 | Insider | 26,800 | $0.37 | Buy | $9,916.00 | |
Nov. 25, 2019 | VP | 75,000 | $0.20 | Buy | $15,000.00 | |
Nov. 25, 2019 | Director | 500,000 | $0.20 | Buy | $100,000.00 | |
Nov. 25, 2019 | CFO | 87,500 | $0.20 | Buy | $17,500.00 | |
Nov. 25, 2019 | Insider | 149,000 | $0.20 | Buy | $29,800.00 | |
Nov. 22, 2019 | Director | 14,555 | $0.59 | Buy | $8,587.45 | |
Sept. 25, 2019 | Director | 7,260 | $1.60 | Buy | $11,616.00 | |
Sept. 23, 2019 | Major Shareholder | 37,242 | $1.23 | Sell | $45,807.66 | |
Sept. 20, 2019 | Major Shareholder | 75,119 | $1.62 | Sell | $121,692.78 | |
Sept. 18, 2019 | Insider | 506,877 | $2.03 | Sell | $1,028,960.31 | |
Sept. 18, 2019 | Major Shareholder | 49,995 | $2.10 | Sell | $104,989.50 | |
Sept. 11, 2019 | Major Shareholder | 1,247 | $2.75 | Sell | $3,429.25 | |
Sept. 9, 2019 | Major Shareholder | 400 | $2.77 | Sell | $1,108.00 | |
Sept. 5, 2019 | Major Shareholder | 400 | $2.75 | Sell | $1,100.00 | |
July 10, 2019 | Major Shareholder | 10,927 | $2.83 | Sell | $30,923.41 | |
June 27, 2019 | Major Shareholder | 1,458 | $3.45 | Sell | $5,030.10 | |
June 25, 2019 | Major Shareholder | 1,380 | $3.40 | Sell | $4,692.00 | |
Aug. 29, 2018 | Director | 99,999 | $0.45 | Sell | $44,999.55 | |
Aug. 27, 2018 | Director | 20,000 | $0.45 | Sell | $9,000.00 | |
May 29, 2018 | Director | 10,000 | $0.38 | Buy | $3,800.00 | |
April 27, 2018 | Major Shareholder | 11,838,235 | $0.43 | Buy | $5,090,441.05 | |
Feb. 8, 2018 | Major Shareholder | 200,000 | $1.04 | Buy | $208,000.00 | |
April 26, 2017 | Director | 119,048 | $2.10 | Buy | $250,000.80 | |
April 26, 2017 | CFO | 1,429 | $2.10 | Buy | $3,000.90 | |
April 26, 2017 | Insider | 23,810 | $2.10 | Buy | $50,001.00 | |
Feb. 21, 2014 | major shareholder | 143,480 | $8.47 | Buy | $1,215,275.60 | |
Feb. 10, 2014 | CEO | 33,543 | $15.07 | Sell | $505,493.01 | |
Feb. 3, 2014 | CEO | 60,000 | $15.05 | Sell | $903,000.00 | |
Jan. 27, 2014 | Director | 57,295 | $11.92 | Buy | $682,956.40 |
Insiders are both buying and selling Onconova Therapeutics Inc stock.
The insider traders at Onconova Therapeutics Inc are: Tyndall Capital Partners L P, Abraham N Oler, Mark Patrick Guerin, E Premkumar Reddy, Ramesh Kumar, Steven M Fruchtman, James J Marino, & Jane Hoffman 2013 De Michael, Abraham N. Oler, 683 Capital Management, Llc, Michael B Hoffman, Michael Hoffman, Viren Mehta, Henry Bienen, Henry S Bienen, Jerome Groopman, and Thomas J Mckearn
The most active insider trader at Onconova Therapeutics Inc is Tyndall Capital Partners L P with 9 trades.
683 Capital Management, Llc has sold the most Onconova Therapeutics Inc stock with a total value of $2,057,920.62.
& Jane Hoffman 2013 De Michael has bought the most Onconova Therapeutics Inc stock with a total value of $17,666,754.20.
The most recent insider trade for Onconova Therapeutics Inc was on Jan. 28, 2022.
The single biggest insider buy for Onconova Therapeutics Inc was from & Jane Hoffman 2013 De Michael with a total value of $15,000,000.00 on July 30, 2013.
The single biggest insider sell for Onconova Therapeutics Inc was from 683 Capital Management, Llc with a total value of $1,028,960.31 on Sept. 18, 2019.